Agency Forms Undergoing Paperwork Reduction Act Review, 6414-6415 [E9-2612]

Download as PDF 6414 Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–2611 Filed 2–6–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–09–0530] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments must be received within 60 days of this notice. Proposed Project Energy Employees Occupational Illness Compensation Program Act (EEOICPA), Dose Reconstruction Interviews and Forms, OMB No. 0920– 0530—Reinstatement—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS). Background and Brief Description On October 30, 2000, the Energy Employees Occupational Illness Compensation Program Act of 2000 (42 U.S.C. 7384–7385) was enacted. This Act established a federal compensation program for employees of the Department of Energy (DOE) and certain of its contractors, subcontractors and vendors, who have suffered cancers and other designated illnesses as a result of exposures sustained in the production and testing of nuclear weapons. Executive Order 13179, issued on December 7, 2000, delegated authorities assigned to ‘‘the President’’ under the Act to the Departments of Labor (DOL), Health and Human Services, Energy and Justice. The Department of Health and Human Services (DHHS) was delegated the responsibility of establishing methods for estimating radiation doses received by eligible claimants with cancer applying for compensation. NIOSH is applying the following methods to estimate the radiation doses of individuals applying for compensation. In performance of its dose reconstruction responsibilities, under the Act, NIOSH is providing voluntary interview opportunities to claimants (or their survivors) individually and providing them with the opportunity to assist NIOSH in documenting the work history of the employee by characterizing the actual work tasks performed. In addition, NIOSH and the claimant may identify incidents that may have resulted in undocumented radiation exposures, characterizing radiological protection and monitoring practices, and identify co-workers and other witnesses as may be necessary to confirm undocumented information. In this process, NIOSH uses a computer assisted telephone interview (CATI) system, which allows interviews to be conducted more efficiently and quickly as opposed to a paper-based interview instrument. Both interviews are voluntary and failure to participate in either or both interviews will not have a negative effect on the claim, although voluntary participation may assist the claimant by adding important information that may not be otherwise available. NIOSH uses the data collected in this process to complete an individual dose reconstruction that accounts, as fully as possible, for the radiation dose incurred by the employee in the line of duty for DOE nuclear weapons production programs. After dose reconstruction, NIOSH also performs a brief, voluntary final interview with the claimant to explain the results and to allow the claimant to confirm or question the records NIOSH has compiled. This will also be the final opportunity for the claimant to supplement the dose reconstruction record. At the conclusion of the dose reconstruction process, the claimant submits a form to confirm that the claimant has no further information to provide to NIOSH about the claim at this time. The form notifies the claimant that signing the form allows NIOSH to forward a dose reconstruction report to DOL and to the claimant, and closes the record on data used for the dose reconstruction. Signing this form does not indicate that the claimant agrees with the outcome of the dose reconstruction. The dose reconstruction results will be supplied to the claimant and to the DOL, the agency that will utilize them as one part of its determination of whether the claimant is eligible for compensation under the Act. There is no cost to respondents other than their time. The total estimated annualized burden hours are 4,900. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Instrument type sroberts on PROD1PC70 with NOTICES Initial interview ................................................................................................................. Conclusion Form .............................................................................................................. VerDate Nov<24>2008 16:35 Feb 06, 2009 Jkt 217001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Number of responses per respondent 4,200 8,400 E:\FR\FM\09FEN1.SGM Average burden (in hours) 1 1 09FEN1 1 5/60 Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices Dated: January 30, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–2612 Filed 2–6–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel, Data Analysis and Coordinating Center for Research Training. Date: March 31, 2009. Time: 3 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: NHGRI Twinbrook Library, 5635 Fishers Lane, Suite 4076, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Keith McKenney, Ph.D, Scientific Review Officer, NHGRI, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20814, 301–594–4280, mckenneyk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: February 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2658 Filed 2–6–09; 8:45 am] amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Cell Fate Determination RFA. Date: March 4, 2009. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Room 2C212, Bethesda, MD 20814 (Telephone Conference Call). Contact Person: Bita Nakhai, PhD, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7701, nakhaib@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel, Roybal Centers for Translational Research on Aging. Date: March 16–17, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Alfonso R. Latoni, PhD, Deputy Chief and Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Room 2C218, Bethesda, MD 20892, 301–402–7702, latonia@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: February 2, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2593 Filed 2–6–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES sroberts on PROD1PC70 with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Nov<24>2008 16:35 Feb 06, 2009 Jkt 217001 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 6415 is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Immune Defense Mechanisms at the Mucosa. Date: March 5–6, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Priti Mehrotra, Ph.D, Scientific Review Administrator, Division of Extramural Activities, NIAID/NIH, 6700B Rockledge Drive, Room 2100, Bethesda, MD 20892–7616, (301) 496–2550, pm158b@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2660 Filed 2–6–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–R8–FHC–2009–N0021; 81331–1334– 8TWG–W4] Trinity Adaptive Management Working Group AGENCY: Fish and Wildlife Service, Interior. ACTION: Notice of meeting. SUMMARY: The Trinity Adaptive Management Working Group (TAMWG) affords stakeholders the opportunity to give policy, management, and technical input concerning Trinity River (California) restoration efforts to the Trinity Management Council (TMC). This notice announces a TAMWG meeting, which is open to the public. DATES: TAMWG will meet from 1 p.m. to 5 p.m. on Monday, March 16, 2009, E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 74, Number 25 (Monday, February 9, 2009)]
[Notices]
[Pages 6414-6415]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2612]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-09-0530]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments must be received 
within 60 days of this notice.

Proposed Project

    Energy Employees Occupational Illness Compensation Program Act 
(EEOICPA), Dose Reconstruction Interviews and Forms, OMB No. 0920-
0530--Reinstatement--The National Institute for Occupational Safety and 
Health (NIOSH), Centers for Disease Control and Prevention (CDC), 
Department of Health and Human Services (DHHS).

Background and Brief Description

    On October 30, 2000, the Energy Employees Occupational Illness 
Compensation Program Act of 2000 (42 U.S.C. 7384-7385) was enacted. 
This Act established a federal compensation program for employees of 
the Department of Energy (DOE) and certain of its contractors, 
subcontractors and vendors, who have suffered cancers and other 
designated illnesses as a result of exposures sustained in the 
production and testing of nuclear weapons.
    Executive Order 13179, issued on December 7, 2000, delegated 
authorities assigned to ``the President'' under the Act to the 
Departments of Labor (DOL), Health and Human Services, Energy and 
Justice. The Department of Health and Human Services (DHHS) was 
delegated the responsibility of establishing methods for estimating 
radiation doses received by eligible claimants with cancer applying for 
compensation. NIOSH is applying the following methods to estimate the 
radiation doses of individuals applying for compensation.
    In performance of its dose reconstruction responsibilities, under 
the Act, NIOSH is providing voluntary interview opportunities to 
claimants (or their survivors) individually and providing them with the 
opportunity to assist NIOSH in documenting the work history of the 
employee by characterizing the actual work tasks performed. In 
addition, NIOSH and the claimant may identify incidents that may have 
resulted in undocumented radiation exposures, characterizing 
radiological protection and monitoring practices, and identify co-
workers and other witnesses as may be necessary to confirm undocumented 
information. In this process, NIOSH uses a computer assisted telephone 
interview (CATI) system, which allows interviews to be conducted more 
efficiently and quickly as opposed to a paper-based interview 
instrument. Both interviews are voluntary and failure to participate in 
either or both interviews will not have a negative effect on the claim, 
although voluntary participation may assist the claimant by adding 
important information that may not be otherwise available.
    NIOSH uses the data collected in this process to complete an 
individual dose reconstruction that accounts, as fully as possible, for 
the radiation dose incurred by the employee in the line of duty for DOE 
nuclear weapons production programs. After dose reconstruction, NIOSH 
also performs a brief, voluntary final interview with the claimant to 
explain the results and to allow the claimant to confirm or question 
the records NIOSH has compiled. This will also be the final opportunity 
for the claimant to supplement the dose reconstruction record.
    At the conclusion of the dose reconstruction process, the claimant 
submits a form to confirm that the claimant has no further information 
to provide to NIOSH about the claim at this time. The form notifies the 
claimant that signing the form allows NIOSH to forward a dose 
reconstruction report to DOL and to the claimant, and closes the record 
on data used for the dose reconstruction. Signing this form does not 
indicate that the claimant agrees with the outcome of the dose 
reconstruction. The dose reconstruction results will be supplied to the 
claimant and to the DOL, the agency that will utilize them as one part 
of its determination of whether the claimant is eligible for 
compensation under the Act.
    There is no cost to respondents other than their time. The total 
estimated annualized burden hours are 4,900.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                  Number of
                      Instrument type                           Number of       responses per    Average burden
                                                               respondents       respondent        (in hours)
----------------------------------------------------------------------------------------------------------------
Initial interview.........................................             4,200                 1                 1
Conclusion Form...........................................             8,400                 1              5/60
----------------------------------------------------------------------------------------------------------------



[[Page 6415]]

    Dated: January 30, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-2612 Filed 2-6-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.